Functional genomics and rheumatoid arthritis: where have we been and where should we go?

scientific article

Functional genomics and rheumatoid arthritis: where have we been and where should we go? is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1013985819
P356DOI10.1186/GM165
P932PMC publication ID2923736
P698PubMed publication ID20670388
P5875ResearchGate publication ID45423122

P2093author name stringJames N Jarvis
Mark Barton Frank
P2860cites workA genome-scale assessment of peripheral blood B-cell molecular homeostasis in patients with rheumatoid arthritisQ53625798
Genetic Susceptibility Loci in Rheumatoid Arthritis Establish Transcriptional Regulatory Networks with Other GenesQ58286172
A comparison of etanercept and methotrexate in patients with early rheumatoid arthritisQ73235899
Cutting edge: molecular portrait of human autoimmune diseaseQ74334835
Gene expression profiling in autoantibody-positive patients with arthralgia predicts development of arthritisQ82777541
Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot projectQ21061203
Novel approaches to gene expression analysis of active polyarticular juvenile rheumatoid arthritisQ24792928
Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingQ27860529
Network biology: understanding the cell's functional organizationQ27861027
Error and attack tolerance of complex networksQ29547268
The large-scale organization of metabolic networksQ29547498
Histone modifications in transcriptional regulationQ29614770
DNA methylation landscapes: provocative insights from epigenomicsQ29617144
Evolving concepts of rheumatoid arthritisQ29618020
Non-coding RNAs: regulators of diseaseQ29618040
Disease-associated pathophysiologic structures in pediatric rheumatic diseases show characteristics of scale-free networks seen in physiologic systems: implications for pathogenesis and treatmentQ33411566
Integrative modeling of transcriptional regulation in response to antirheumatic therapyQ33496328
Transcriptome analysis describing new immunity and defense genes in peripheral blood mononuclear cells of rheumatoid arthritis patientsQ33497339
An eight-gene blood expression profile predicts the response to infliximab in rheumatoid arthritis.Q33511764
Risk of cancer among rheumatoid arthritis patients in CaliforniaQ35162890
A gene expression signature for recent onset rheumatoid arthritis in peripheral blood mononuclear cellsQ35553508
Rheumatic disease in Native American children: opportunities and challengeQ35580558
Gene profiling in white blood cells predicts infliximab responsiveness in rheumatoid arthritisQ35605604
Evidence for chronic, peripheral activation of neutrophils in polyarticular juvenile rheumatoid arthritisQ35605713
Diagnostic and prognostic potential of gene microarrays in rheumatoid arthritisQ36252156
Expression and regulation of CCL18 in synovial fluid neutrophils of patients with rheumatoid arthritisQ36401957
Molecular discrimination of responders and nonresponders to anti-TNF alpha therapy in rheumatoid arthritis by etanerceptQ36790328
Coupling and coordination in gene expression processes: a systems biology viewQ37028776
Epigenetics in rheumatoid arthritis.Q37587047
Emerging similarities in epigenetic gene silencing by long noncoding RNAsQ37591357
Rheumatoid arthritis genetics: 2009 updateQ37601576
Mortality in rheumatoid arthritis and ankylosing spondylitisQ37613130
Evidence for microRNA-mediated regulation in rheumatic diseasesQ37649034
Inflammation, vascular injury and repair in rheumatoid arthritis.Q37649055
Update on the genetic risk factors for rheumatoid arthritisQ37729042
Expression of a pathogen-response program in peripheral blood cells defines a subgroup of rheumatoid arthritis patientsQ38297424
Gene expression profiling in neutrophils from children with polyarticular juvenile idiopathic arthritisQ41836488
Discovery of distinctive gene expression profiles in rheumatoid synovium using cDNA microarray technology: evidence for the existence of multiple pathways of tissue destruction and repairQ47968062
Prediction of efficacy of anti-TNF biologic agent, infliximab, for rheumatoid arthritis patients using a comprehensive transcriptome analysis of white blood cellsQ51565108
P433issue7
P921main subjectrheumatoid arthritisQ187255
genomicsQ222046
functional genomicsQ1068690
P304page(s)44
P577publication date2010-07-28
P13046publication type of scholarly workreview articleQ7318358
P1433published inGenome MedicineQ15816848
P1476titleFunctional genomics and rheumatoid arthritis: where have we been and where should we go?
P478volume2

Reverse relations

cites work (P2860)
Q38706445Advances in the delivery of RNA therapeutics: from concept to clinical reality.
Q55513036Disease-specific regulation of gene expression in a comparative analysis of juvenile idiopathic arthritis and inflammatory bowel disease.
Q39243858Juvenile idiopathic arthritis: management and therapeutic options
Q37072649Limits of Peripheral Blood Mononuclear Cells for Gene Expression-Based Biomarkers in Juvenile Idiopathic Arthritis
Q89238947RNA sequencing data from neutrophils of patients with cystic fibrosis reveals potential for developing biomarkers for pulmonary exacerbations
Q33828973Whole blood gene expression profiling predicts therapeutic response at six months in patients with polyarticular juvenile idiopathic arthritis

Search more.